Merck submits Rotateq BLA

MRK disclosed that on April 5 it submitted a BLA to FDA for Rotateq rotavirus vaccine to protect against rotavirus gastroenteritis. The live, oral vaccine contains five human serotypes (G1, G2, G3, G4...